🔗 Share this article

The top legal official in Texas Paxton is suing the makers of acetaminophen, claiming the firms hid alleged dangers that the drug presented to pediatric cognitive development.

This legal action arrives thirty days after Former President Trump publicized an unverified association between consuming Tylenol - referred to as acetaminophen - throughout gestation and autism in young ones.

The attorney general is taking legal action against Johnson & Johnson, which formerly manufactured the medication, the exclusive pain medication recommended for women during pregnancy, and Kenvue, which currently produces it.

In a official comment, he claimed they "misled consumers by gaining financially from discomfort and pushing pills ignoring the potential hazards."

The company asserts there is insufficient reliable data linking Tylenol to autism spectrum disorder.

"These corporations misled for generations, knowingly endangering countless individuals to increase profits," Paxton, a Republican, stated.

The manufacturer said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the security of acetaminophen and the likely effects that could have on the health of American women and children."

On its website, the company also mentioned it had "continuously evaluated the relevant science and there is no credible data that indicates a verified association between using paracetamol and autism."

Organizations speaking for doctors and medical practitioners agree.

ACOG has declared paracetamol - the key substance in acetaminophen - is among limited choices for women during pregnancy to address pain and fever, which can create serious health risks if not addressed.

"In more than two decades of studies on the utilization of paracetamol in gestation, no reliable research has definitively established that the consumption of paracetamol in any period of gestation results in brain development issues in young ones," the group said.

The court filing cites recent announcements from the previous government in asserting the drug is potentially dangerous.

Recently, Trump generated worry from medical authorities when he instructed women during pregnancy to "resist strongly" not to take Tylenol when ill.

The FDA then released a statement that doctors should think about restricting the consumption of Tylenol, while also stating that "a causal relationship" between the medication and autism in minors has not been proven.

The Health Department head Kennedy, who supervises the FDA, had vowed in spring to conduct "extensive scientific investigation" that would determine the cause of autism in a short period.

But authorities advised that identifying a sole reason of autism - considered by experts to be the result of a complicated interplay of genetic and surrounding conditions - would not be simple.

Autism spectrum disorder is a type of enduring cognitive variation and disability that impacts how individuals perceive and relate to the world, and is identified using physician assessments.

In his legal document, Paxton - who supports Trump who is campaigning for federal office - asserts the manufacturer and Johnson & Johnson "willfully ignored and attempted to silence the research" around paracetamol and autism.

The lawsuit seeks to make the companies "eliminate any marketing or advertising" that states acetaminophen is safe for women during pregnancy.

This legal action mirrors the concerns of a collection of parents of young ones with autism spectrum disorder and ADHD who took legal action against the makers of Tylenol in two years ago.

Judicial authorities dismissed the legal action, declaring investigations from the parents' expert witnesses was lacking definitive proof.